Repatha (evolocumab) is a PCSK9 inhibitor used for lowering LDL cholesterol. One of its common side effects includes musculoskeletal pain, such as muscle aches and cramps. According to the FDA package insert for Repatha, clinical trials observed arthralgia, myalgia, and back pain as notable adverse events.

In contrast:

Requip (ropinirole) may cause dizziness or nausea.

Restasis (cyclosporine ophthalmic) causes eye irritation.

Restoril (temazepam) is associated with sedation.